miRNAs: novel noninvasive biomarkers as diagnostic and prognostic tools in neonatal sepsis.

The study aimed to assess the diagnostic and prognostic value of 3 specific microRNAs (miRNAs) in early-onset neonatal sepsis (NS). We examined miR-1, miR-124, and miR-34a in 70 NS patients upon admission and compared them to 70 healthy controls by RT-PCR. The main finding of the study was the difference in miRNA expression levels between NS patients and controls. Higher expression levels of miR-1 and miR-124 were significantly associated with NS, while miR-34a expression was reduced. Among the studied miRNAs, miR-34a exhibited the highest specificity (97%) as a confirmatory test for NS. In the multivariate model, miR-1 and miR-124 were found to be significant predictors of disease progression or mortality. Overall, the study suggests that miR-1, miR-124, and miR-34a could serve as potential biomarkers for diagnosing and predicting outcomes in early-onset NS.Copyright © 2023 Elsevier Inc. All rights reserved.

Citation

Nashwa El-Khazragy, Noura Mostafa Mohamed, Mohamed Fathalla Mostafa, Mostafa Elnakib, Eman H A Hemida, Amira Salah, Nesma Mohamed Fawzy, Gehan Safwat, Mennatallah M Emam, Nievin Ahmed Mahran, Dina Rabie. miRNAs: novel noninvasive biomarkers as diagnostic and prognostic tools in neonatal sepsis. Diagnostic microbiology and infectious disease. 2023 Aug 09;107(3):116053116053

PMID: 37659119

search → result